Skip to main content
SpringerLink
Log in

Interferons Combined with Other Anti-Cancer Agents — Studies in Experimental Systems

  • Conference paper
Interferons in Oncology

Part of the book series: ESO Monographs ((ESO MONOGRAPHS))

Abstract

It seems likely that the most effective uses of interferons (IFNs) in cancer will come in combination with other treatment modalities (1). The interactions between IFNs and many cytotoxic drugs have been extensively studied in experimental cancer systems using both in vivo and in vitro models.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Borden EC, Hawkins MJ: Biologic response modifiers as adjuncts to other therapeutic modalities. Semin Oncol 1986 (13):144–152

    PubMed  CAS  Google Scholar 

  2. Chirigos MA, Pearson JW: Cure of murine leukemia with drug and interferon treatment. J Natl Cancer Inst 1973 (51):1367–1368

    PubMed  CAS  Google Scholar 

  3. Gresser I, Maury C, Tovey M: Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR mice. Eur J Cancer 1978 (14):97–99

    PubMed  CAS  Google Scholar 

  4. Tozawa M, Kidowaki T, Tanaka T, Sawada T, Kusunoki T, Oku T, Kishida T: Effects of interferon on C1300 mouse neuroblastoma. Cancer Treat Rep 1982 (66):1575–1577

    PubMed  CAS  Google Scholar 

  5. Heremans H, Billiau A, De Somer M: Effect of interferon on the growth of tumours in experimental murine models. In: De Maeyer E and Schellekens H (eds) The biology of the interferon system. Amsterdam: Elsevier Science Publishers BV 1983:425–430

    Google Scholar 

  6. Borden EC, Sidky T, Groveman D, Bryan GT: Antitumour effects of polyribonucleotides for mouse transitional cell carcinoma enhanced by cyclophosphamide. Cancer Res 1985 (45):45–50

    Article  PubMed  CAS  Google Scholar 

  7. Mowshowitz SL, Chin-Bow ST, Smith GD: Interferon and cis-DDP: Combination chemotherapy for P388 leukaemia in CDF 1 mice. J Interfer Res 1982 (2):587–591

    Article  CAS  Google Scholar 

  8. Slater LM, Wetzel MW, Cesario T: Combined interferon-anti-metabolite therapy of murine L1210 leukemia. Cancer 1981 (48):5–9

    Article  PubMed  CAS  Google Scholar 

  9. Sunkara PS, Prakash NJ, Mayer GD, Sjoerdsma A: Tumor suppression with a combination of alpha-DFMO and interferon. Science 1983 (219):851–853

    Article  PubMed  CAS  Google Scholar 

  10. Balkwill FR, Moodie EM: Positive interactions between human interferon and cyclophosphamide or Adriamycin on a human model system. Cancer Res 1984 (44):904–908

    PubMed  CAS  Google Scholar 

  11. Carmichael J, Fergusson RJ, Wolf CR, Balkwill FR, Smyth JF: Augmentation of cytotoxicity of chemotherapy by human alpha interferons in human non-small cell lung cancer xenografts. Cancer Res 1986 (46):4916–4920

    PubMed  CAS  Google Scholar 

  12. Heston WDW, Fleischmann J, Tackett RE, Ratliff TL: Effects of alpha-difluoromethylornithine and recombinant interferon alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice. Cancer Res 1984 (44):3220–3225

    PubMed  CAS  Google Scholar 

  13. Streevalsan T, Taylor-Papadimitriou J, Rozengurt E: Selective inhibition by interferon of serum-stimulated biochemical events in 3T3 cells. Biochem Biophys Res Commun 1979 (87):679–685

    Article  Google Scholar 

  14. Metcalf BW, Bey P, Danzin C, Jung MJ, Casara P, Vevert JP: Catalytic irreversible inhibition of mammalian ornithine decarboxylase by substrate and product analogues. J Am Chem Soc 1978 (100):2551–2553

    Article  CAS  Google Scholar 

  15. Welander CE, Morgan TM, Homesley HD, Trotta PP, Spiegel RJ: Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay. Int J Cancer 1985 (35):721–729

    Article  PubMed  CAS  Google Scholar 

  16. Morris L, Spiegel R: In vitro synergistic effect of recombinant human interferon alpha-2 and Adriamycin in a human Burkitt’s lymphoma cell line. Proc Am Assoc Cancer Res 1984 (25):318

    Google Scholar 

  17. Ho CK: Synergistic anticellular effect of a combination of beta-interferon and retinoic acid against U937 cells. Cancer Res 1985 (45):5348–5351

    PubMed  CAS  Google Scholar 

  18. Aapro MS, Alberts DS, Salmon SE: Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay. Cancer Chemother Pharmacol 1983 (10):161–166

    Article  PubMed  CAS  Google Scholar 

  19. Kyle G, Woolley P, Kumar S, Mossman K: Antiproliferative effects of human recombinant interferon in combination with radiation and chemotherapeutic drugs in five human cell lines. Proc Am Assoc Cancer Res 1985 (26):327

    Google Scholar 

  20. Takahashi I, Oday Y, Lai M, Fukumoto M, Nishimura M, Yorimitsu M, Kitajama K, Kimura I: Interaction between human lymphoblastoid interferon and chemotherapeutic agents in vitro. Acta Med Okayama 1984 (38):501–504

    PubMed  CAS  Google Scholar 

  21. Kuebler JP, Borden EC, Bryan GT, Epstein RB: In vitro growth inhibition of human renal cell carcinoma in the presence of recombinant interferon-beta and vinblastine. Proc Am Assoc Cancer Res 1985 (26):322

    Google Scholar 

  22. Marquet RJ, Schellekens H, Westbroek DL, Jeekel J: Effects of treatment with interferon and cyclophosphamide on the growth of a spontaneous liposarcoma in rats. Int J Cancer 1983 (31):223–226

    Article  PubMed  CAS  Google Scholar 

  23. Marquet RJ, Schellekens H, Dijkema R, Westbroek DL, Jeekel J: Effects of interferon and chemotherapy on tumour growth in rats. In: De Maeyer E and Schellekens H (eds) The Biology of the Interferon System. Amsterdam: Elsevier Science Publishers BV 1983

    Google Scholar 

  24. Smith PK, Nerland DE, Sonnenfeld G: Effect of interferon onmurine cytochrome P-450: Effect of partially purified antigen-specific interferon-gamma. J Interfer Res 1983 (3):219–222

    Article  CAS  Google Scholar 

  25. Balkwill FR, Mowshowtiz S, Seilman SS, Moodie EM, Griffin DD, Fantes KH, Wolf CR: Positive interactions between interferons and chemotherapy due to direct tumour action rather than effects on host drug metabolising enzymes. Cancer Res 1984 (44):5249–5255

    PubMed  CAS  Google Scholar 

  26. Balkwill FR, Moodie EM, Freedman V, Fantes KH: Human interferon inhibits the growth of established human breast tumours in the nude mouse. Int J Cancer 1982 (30):231–235

    Article  PubMed  CAS  Google Scholar 

  27. Djeu JY, Heinbaugh JA, Holden HT, Heberman RB: Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 1979 (122):175–181

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Imperial Cancer Research Fund, Medical Oncology Unit, Department of Clinical Oncology, Western General Hospital, Edinburgh, EH4 2XU, Scotland, UK

    J. F. Smyth & R. J. Fergusson

  2. Imperial Cancer Research Fund Laboratories, 44, Lincoln’s Inn Fields, London, WC2A 3PX, UK

    F. R. Balkwill

Authors
  1. J. F. Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. R. Balkwill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. J. Fergusson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial Cancer Research Fund Medical Oncology Unit, Western General Hospital, Edinburgh, EH4 2XU, Great Britain

    John F. Smyth

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Smyth, J.F., Balkwill, F.R., Fergusson, R.J. (1987). Interferons Combined with Other Anti-Cancer Agents — Studies in Experimental Systems. In: Smyth, J.F. (eds) Interferons in Oncology. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72805-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72805-1_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72807-5

  • Online ISBN: 978-3-642-72805-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation